2010 to 2021 Saw Rise in Postpartum Depression
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- Diagnosis of postpartum depression increased significantly across all racial and ethnic groups and body mass index categories over the past decade, according to a study published online Nov. 20 in JAMA Network Open.
Nehaa Khadka, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues evaluated recent trends in postpartum depression to see how these trends are associated with race, ethnicity, and prepregnancy body mass index. The analysis included electronic health record data, with live and stillbirths at ≥20 weeks of gestation, for 442,308 pregnancies with delivery between 2010 and 2021.
The researchers found that postpartum depression prevalence doubled during the study period, increasing from 9.4 percent in 2010 to 19.0 percent in 2021. There were differences seen in increase by race and ethnicity, with the largest increases among Asian and Pacific Islander participants (280 percent increase) and non-Hispanic Black women (140 percent increase). Across body mass index categories, PPD rates increased, particularly among individuals with obesity (class I) and morbid obesity (class II/III).
"While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Electroconvulsive Therapy Reduces Mortality in People With Depression
WEDNESDAY, June 18, 2025 -- Electroconvulsive therapy (ECT) shows a significant protective effect against suicide and overall mortality in people with depression, according to a...
Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression
MONDAY, June 16, 2025 -- For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for...
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.